Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH

miRNAs are involved in the development of metabolic associated fatty liver disease (MAFLD) and nonalcoholic steatohepatitis (NASH). We aimed to evaluate modifications by prolonged-release pirfenidone (PR-PFD) on key hepatic miRNAs expression in a MAFLD/NASH model. First, male C57BL/6J mice were rand...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Escutia-Gutiérrez, Rebeca, Rodríguez-Sanabria, J. Samael, Monraz-Méndez, C. Alejandra, García-Bañuelos, Jesús, Santos-García, Arturo, Sandoval-Rodríguez, Ana, Armendáriz-Borunda, Juan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8175718/
https://ncbi.nlm.nih.gov/pubmed/34083664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-91187-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia